Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →Filing growth compares 2021 (73 records) with 2024 (58) — a three-year span. 2024 is the most recent year we treat as complete: publication lags filing by roughly 18 months, so 2025 onwards are still filling in and any growth rate that ends there would understate the field. Top-5 share is the combined record count of the five largest assignees divided by all 4,984 records in scope (CR5), not by the ranked leaders only.
Wet strength resin chemistry sits at the intersection of polymer science and papermaking process engineering: polyamidoamine epichlorohydrin (PAE) and glyoxalated polyacrylamide (GPAM) systems are the two dominant chemical routes, and the search underlying this dataset pulls records that combine either route with downstream process concerns — temporary wet strength, AOX reduction, repulpability, cure development, retention systems and tissue application. That combination matters commercially: a resin that delivers strength but fails repulpability or trips AOX limits does not clear regulatory or recycling hurdles, regardless of its polymer chemistry.
The scope spans 4,984 published records from 2015 through the 2026-07-31 cut-off, ranked across 100 assignees and classified across eight IPC subclasses that together describe where the claim activity actually lands — from bulk pulp compositions through to sanitary products and mechanical converting equipment.
Pick a task. Every answer cites the patents behind it.
Two views of the same 4,984-record set: how filing volume has moved year over year, and which IPC subclasses carry the claim density.
Filings peaked at 245 in 2017 and have since declined; the cleanest comparison available — 2021 (73) versus 2024 (58) — shows a 21% drop over three years. 2025 and 2026 figures are necessarily incomplete because publication typically lags filing by around 18 months, so the most recent bars will fill in over time rather than confirming a further decline.
D21H (pulp and paper compositions) covers 74.4% of the 4,984 records, far ahead of D21F (paper-making machines, 21.7%) and A47K (sanitary and bathroom equipment, 13.6%). Because records can carry multiple IPC classes, these shares sum to well over 100% — they describe overlap in claim scope, not a partition of the dataset.
Shares are the percentage of the 4,984 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
This page is one run against one query. Ask Eureka your own question about wet strength resins for paper and every answer comes back with the patent numbers behind it.
Try EurekaA multi-ply bath tissue includes cellulosic microfibers and wood pulp fibers. The bath tissue has sufficient temporary wet strength resin to provide an initial Finch Cup cross-machine direction wet tensile within a defined range, decaying to less than 65% of the initial value within 15 minutes of immersion, combined with a specified caliper per basis weight. At least one ply includes fiber-enriched hollow domed regions of higher basis weight interconnected by lower-basis-weight regions.Assigned to GPCP IP Holdings LLC, published 2018-01-30.


| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | US6261679B1 | Fibrous absorbent material and methods of making the same | 1,318 |
| 2 | US5672248A | Method of making soft tissue products | 896 |
| 3 | US6017417A | Method of making soft tissue products | 610 |
| 4 | US4605702A | Temporary wet strength resin | 572 |
| 5 | US6610173B1 | Three-dimensional tissue and methods for making the same | 530 |
| 6 | US4981557A | Temporary wet strength resins with nitrogen heterocyclic nonnucleophilic functionalities and paper products c… | 489 |
| 7 | US5990377A | Dual-zoned absorbent webs | 475 |
| 8 | US7494563B2 | Fabric creped absorbent sheet with variable local basis weight | 464 |
| 9 | US5556509A | Paper structures having at least three regions including a transition region interconnecting relatively thinn… | 463 |
| 10 | US5223096A | Soft absorbent tissue paper with high permanent wet strength | 458 |
Citation counts favour older records simply because they have had longer to accumulate citations inside the searched corpus — treat this table as a map of influence, not of current commercial importance.
Each row carries its publication number; clicking a row searches Eureka by that number.
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →Three read-throughs from the concentration, technology and citation data — useful for deciding where a new filing has room to stand and where it will simply add to prior art density.
With the top five assignees holding 72.3% of all records and the top ten holding 83.1%, new entrants are filing into claim space already dense with tissue and chemical majors. A freedom-to-operate search here needs to start with the leaders' portfolios, not a broad landscape scan.
D21H's dominance reflects where the underlying chemistry gets claimed — resin formulation and cure behaviour — while D21F, A47K and B31F capture the machine, product-form and converting angles that build around that chemistry. A filing strategy that only targets D21H is competing head-on with the most crowded subclass in the set.
The 2017 peak of 245 filings has not been repeated, and the clean 2021-to-2024 comparison confirms a real three-year decline. Because publication lags filing by roughly 18 months, the 2025-2026 figures understate true filing activity and should not be read as evidence the decline is continuing.
The most-cited records in this landscape date from the 1980s through early 2000s, well before the 2015 scope start, which is consistent with citation counts favouring age over recency. Their persistence in citation chains signals foundational technique rather than current filing activity.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to wet strength resins for paper, with the prior art for and against each one.
The ranking covers all 100 assignees the data endpoint returns for this scope — a long tail beneath a concentrated top, with recent-year momentum data showing most leaders pulling back from their historic filing pace.
The leading assignee's 1,694 records is roughly ten times the tenth-place total of 87, an unusually steep drop-off that marks this as a field shaped by one dominant filer rather than several evenly matched competitors.
Recent-year momentum data shows the leading assignee down to single-digit filings with an 81% year-on-year drop, and most other tracked assignees flat or down sharply too. One smaller filer bucks the trend with a 100% year-on-year increase, though off a small base.
The strongest co-assignee links in this dataset pair a single company with named individual inventors rather than linking two separate corporate assignees, suggesting collaboration here is largely internal R&D team structure rather than joint-venture filing.
| Assignee | Recent year | YoY |
|---|---|---|
| Procter & Gamble | 3 | -81% |
| First Quality Tissue LLC | 2 | +100% |
| Kimberly-Clark Worldwide, Inc. | 1 | -83% |
| Solenis Technologies Cayman L.P. | 1 | -50% |
| Georgia-Pacific Consumer Products LP | 0 | — |
| Kemira Oyj (Finland) | 0 | -100% |
| GPCP IP Holdings LLC | 0 | -100% |
| Fort James Corporation | 0 | — |
The landscape points to a consolidated field with a cooling filing pace at the top and specific under-claimed branches worth checking against a live freedom-to-operate search.
With 72.3% of records held by five assignees, any new filing should be checked against those specific portfolios before broader landscape work, not after it.
Explore assignee portfolios in EurekaAOX-reduction and repulpability-triggered chemistry show filing activity well below D21H's density — worth monitoring for new entrants before the space fills in.
Set up monitoring in EurekaCurrent data understates the last 18 months of filing activity; revisit the trend chart in six to twelve months for a fairer read on whether the decline continues.
Open the live trend view in EurekaThe two dominant chemistries tracked in this landscape are polyamidoamine epichlorohydrin (PAE) resins and glyoxalated polyacrylamide (GPAM) systems. PAE resins are the longer-established route and deliver permanent-type wet strength, while GPAM systems are more commonly associated with temporary wet strength that decays after wetting, which matters for flushability and repulpability requirements. Both routes appear heavily in the D21H pulp and paper composition subclass, which covers 74.4% of the 4,984 records in this scope, and the choice between them in a given filing usually tracks whether the end product needs permanent or temporary strength.
Filing in this space is highly concentrated: the top five assignees account for 3,604 of the 4,984 records in scope, or 72.3%, and the top ten account for 83.1%. The single leading assignee holds 1,694 records, roughly ten times the tenth-place total of 87. Recent-year momentum data shows most of these leaders filing far less than their historic pace, with the top assignee down 81% year-on-year in the latest tracked year, so leadership by cumulative volume does not necessarily mean leadership in current filing activity.
Filing peaked at 245 records in 2017 and the cleanest available comparison, 2021's 73 filings against 2024's 58, shows a 21% decline over that three-year span. This is consistent with a mature, consolidated field where the largest players already hold dense claim positions and have less need to keep filing at peak rates. It is important not to over-read the very latest years: publication typically lags filing by around 18 months, so 2025 and 2026 figures in any dataset will understate true activity and should not be treated as confirming a continuing drop.
US9879382B2, assigned to GPCP IP Holdings LLC and published in January 2018, claims a multi-ply bath tissue that uses temporary wet strength resin dosed to hit a specific Finch Cup cross-machine wet tensile range that decays to less than 65% of its initial value within 15 minutes of wetting, combined with a defined caliper per basis weight and a particular hollow-domed ply structure. Anyone designing a temporary-wet-strength tissue product with similar decay kinetics and ply geometry should review this claim's specific numeric ranges closely, since the patent is structured around those thresholds rather than the resin chemistry alone. Products that use a different decay profile, caliper range, or ply structure sit outside the literal claim scope, but a design-around still needs a full claim chart rather than a read of the abstract.
The technology composition data shows claim density is heavily weighted toward D21H pulp and paper compositions (74.4% of records), with much lower activity in adjacent branches like implant and absorbent-laminate crossover applications (A61F, 7.4%) and layered laminate structures (B32B, 6.4%). Sub-areas tied to specific process concerns in the search scope, such as AOX-reduction cure chemistry and repulpability-triggered resin breakdown, show meaningful activity without anything like D21H's filing density. That gap suggests narrower, mechanism-specific claims in those branches have more room than a broad formulation claim would in the core pulp and paper composition space.
Go past this page: query the whole wet strength resins for paper corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company's registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.
Help us improve
Something wrong, out of date, or missing on this page? Tell us and it goes straight to the team that maintains it.
This page